SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Chronic kidney disease, cardiovascular risk markers and total mortality in older men: cystatin C versus creatinine.

Zonoozi, S; Ramsay, SE; Papacosta, O; Lennon, LT; Ellins, EA; Halcox, JPJ; Whincup, P; Wannamethee, SG (2019) Chronic kidney disease, cardiovascular risk markers and total mortality in older men: cystatin C versus creatinine. J Epidemiol Community Health, 73 (7). pp. 645-651. ISSN 1470-2738 https://doi.org/10.1136/jech-2018-211719
SGUL Authors: Whincup, Peter Hynes

[img] Microsoft Word (.docx) Accepted Version
Available under License ["licenses_description_publisher" not defined].

Download (98kB)

Abstract

BACKGROUND: It remains uncertain whether cystatin C is a superior marker of renal function than creatinine in older adults. We have investigated the association between estimated glomerular filtration rate (eGFR) using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equations based on creatinine (CKD-EPIcr) and cystatin C (CKD-EPIcys), and cardiovascular risk markers and mortality in older adults. METHODS: This is a cross-sectional and prospective study of 1639 British men aged 71-92 years followed up for an average of 5 years for mortality. Cox survival model and receiving operating characteristic analysis were used to assess the associations. RESULTS: The prevalence of chronic kidney disease (CKD) was similar using the two CKD-EPI equations, although cystatin C reclassified 43.9% of those with stage 3a CKD (eGFR 45-59 mL/min/1.732, moderate damage) to no CKD. However, CKD stages assessed using both CKD-EPIcr and CKD-EPIcys were significantly associated with vascular risk markers and with all-cause and cardiovascular disease mortality. In all men with CKD (eGFR <60 mL/min/1.732), the HRs (95% CI) for all-cause mortality after adjustment for cardiovascular risk factors compared with those with no CKD were 1.53 (1.20 to 1.96) and 1.74 (1.35 to 2.23) using CKD-EPIcr and CKD-EPIcys, respectively. Comparisons of the two CKD equations showed no significant difference in their predictive ability for mortality (difference in area under the curve p=0.46). CONCLUSION: Despite reclassification of CKD stages, assessment of CKD using CKD-EPIcys did not improve prediction of mortality in older British men >70 years. Our data do not support the routine use of CKD-EPIcys for identifying CKD in the elderly British male population.

Item Type: Article
Additional Information: This article has been accepted for publication in Journal of Epidemiology and Community Health, 2019 following peer review, and the Version of Record can be accessed online at http://dx.doi.org/10.1136/jech-2018-211719
Keywords: cardiovascular disease, epidemiology, mortality, 1117 Public Health And Health Services, 1604 Human Geography, Epidemiology
SGUL Research Institute / Research Centre: Academic Structure > Population Health Research Institute (INPH)
Journal or Publication Title: J Epidemiol Community Health
ISSN: 1470-2738
Language: eng
Dates:
DateEvent
10 June 2019Published
19 March 2019Published Online
2 March 2019Accepted
Publisher License: Publisher's own licence
Projects:
Project IDFunderFunder ID
RG/13/16/30528British Heart Foundationhttp://dx.doi.org/10.13039/501100000274
PG/09/024British Heart Foundationhttp://dx.doi.org/10.13039/501100000274
PubMed ID: 30890591
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/110784
Publisher's version: https://doi.org/10.1136/jech-2018-211719

Actions (login required)

Edit Item Edit Item